UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Ledyard National Bank

Ledyard National Bank raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 0.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 16,403 shares of the healthcare conglomerate’s stock after purchasing an additional 78 shares during the period. Ledyard National Bank’s holdings in UnitedHealth Group were worth $8,636,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. Robbins Farley acquired a new position in UnitedHealth Group during the 3rd quarter worth $25,000. Richelieu Gestion SA acquired a new position in UnitedHealth Group during the 4th quarter valued at about $26,000. CGC Financial Services LLC lifted its stake in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the period. NewSquare Capital LLC raised its holdings in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA boosted its stake in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Stock Down 1.3 %

Shares of UnitedHealth Group stock traded down $6.35 during midday trading on Monday, reaching $489.00. 2,192,486 shares of the company’s stock traded hands, compared to its average volume of 4,479,956. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The company has a market cap of $449.92 billion, a price-to-earnings ratio of 29.89, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company’s 50 day simple moving average is $485.19 and its 200 day simple moving average is $513.81.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the business earned $6.26 EPS. The firm’s revenue was up 8.6% compared to the same quarter last year. Equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on UNH shares. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Piper Sandler raised their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Wells Fargo & Company decreased their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

Get Our Latest Research Report on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.